KLK3 and metastatic neoplasm: Notably, our response rate was independent of factors such as the extent of metastatic disease but was generally greater in patients with a high baseline ALP, a low baseline PSA, and no use of strong opioids, although a direct impact of opioids on bone pain is a potential confounding factor.